Today: 8 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Manulife Financial (MFC) Stock in December 2025: New Asia Moves, Dividend Power and 2026 Forecast

Manulife Financial (MFC) Stock in December 2025: New Asia Moves, Dividend Power and 2026 Forecast

Updated: December 2, 2025 Manulife Financial Corporation (TSX:MFC, NYSE:MFC) is heading into the final weeks of 2025 near its 52‑week highs, backed by record earnings, a refreshed strategy in Asia, and a growing dividend. The first days of December have already brought fresh headlines: an asset sale in Vietnam, new leadership for high‑net‑worth clients in Asia, and evidence of continued institutional buying in the stock. Asia Insurance Review+2Hubbis+2 Below is a detailed look at the latest news since December 1, 2025, how it fits into Manulife’s strategy, and what consensus forecasts say about MFC stock going into 2026. Where Manulife
2 December 2025
··
Barrick Mining Corporation (NYSE: B, TSX: ABX) Stock Soars on North American Gold IPO Plan – Latest News, Analyst Targets and 2025–2030 Outlook

Barrick Mining Corporation (NYSE: B, TSX: ABX) Stock Soars on North American Gold IPO Plan – Latest News, Analyst Targets and 2025–2030 Outlook

Updated: December 2, 2025 Barrick Mining Corporation stock has surged back to levels not seen in more than a decade as the gold miner rides record bullion prices, activist pressure and a newly announced plan to float its premier North American gold assets in a separate vehicle. Below is a detailed look at all the key news, forecasts and analyses since December 1, 2025, plus what they may mean for investors looking at Barrick Mining (still widely searched under its former name Barrick Gold). Key takeaways December 1–2, 2025: What exactly did Barrick announce? On December 1, 2025, Barrick’s board
2 December 2025
···
Toronto-Dominion Bank Stock (TD): December 2025 Outlook Ahead of Q4 Earnings, AML Overhang and Dividend Growth

Toronto-Dominion Bank Stock (TD): December 2025 Outlook Ahead of Q4 Earnings, AML Overhang and Dividend Growth

TORONTO — As of early December 2025, Toronto-Dominion Bank (TSX: TD, NYSE: TD) is trading near record highs, with investors positioning for Q4 2025 earnings on December 4 and still weighing the fallout from its US$3 billion anti–money laundering (AML) settlement in the United States. Reuters+2MarketBeat+2 Here’s a detailed, news‑driven look at Toronto-Dominion Bank stock using the latest information from 1 December 2025 onward, including price action, analyst forecasts, dividend trends and regulatory risk. TD Stock Price in December 2025: Near Highs After a Huge 2025 Rally On the Toronto Stock Exchange, a December 1 analysis from Meyka shows TD.TO
2 December 2025
·
Bank of Nova Scotia (BNS) Stock Near 52‑Week High: Davivienda Deal, Q4 2025 Earnings Preview and 2026 Forecast

Bank of Nova Scotia (BNS) Stock Near 52‑Week High: Davivienda Deal, Q4 2025 Earnings Preview and 2026 Forecast

As of December 2, 2025, Bank of Nova Scotia stock (Scotiabank, TSX: BNS, NYSE: BNS) is trading close to its 52‑week high, just hours before it reports fourth‑quarter 2025 earnings. At the same time, the bank has closed a major Latin American transaction with Davivienda, and analysts are warning that Canada’s big banks are priced for perfection. This article pulls together all the key news, forecasts, and analyses published since December 1, 2025, and explains what they mean for BNS stock over the next year. Key takeaways on Bank of Nova Scotia stock today BNS stock price and valuation snapshot
2 December 2025
··
Equinix (EQIX) Stock: SEC Probe Ends, AI Supercomputer Deal and 2026 Price Targets – December 1, 2025 Outlook

Equinix (EQIX) Stock: SEC Probe Ends, AI Supercomputer Deal and 2026 Price Targets – December 1, 2025 Outlook

Equinix, Inc. (NASDAQ: EQIX) enters December 2025 as one of the most closely watched AI‑data‑center REITs on Wall Street. The stock has lagged both its real estate peers and the broader market this year, yet analysts still see meaningful upside driven by robust AI infrastructure demand, record bookings and a clearer regulatory backdrop. As of Monday, December 1, 2025, Equinix shares closed at $733.28, down 2.66% on the day and roughly 26% below their 52‑week high of $989.84 reached last December. MarketWatch Despite that drawdown, most major research aggregators still rate EQIX a “Strong Buy” with average 12‑month price targets
2 December 2025
···
Cintas Stock (CTAS) on December 1, 2025: Price, Q1 2026 Earnings Beat, Dividend Hike and 2026–2028 Forecast

Cintas Stock (CTAS) on December 1, 2025: Price, Q1 2026 Earnings Beat, Dividend Hike and 2026–2028 Forecast

Cintas Corporation (NASDAQ: CTAS) heads into December 2025 as a classic “quality compounder” that has finally pulled back from record highs. The uniform and facility services specialist just delivered another beat‑and‑raise quarter, announced a fresh $1 billion buyback, and extended a decades‑long dividend growth streak — yet the stock is still trading well below its June peak. This article looks at where Cintas stock stands today, what the latest earnings and capital‑return moves mean, and how Wall Street currently values CTAS through 2026–2028. This coverage is based on public information available up to December 1, 2025 and is for informational
2 December 2025
···
Aon plc (AON) Stock Outlook – December 2025: Earnings Beat, $2.7 Billion Divestiture and Fresh Analyst Price Targets

Aon plc (AON) Stock Outlook – December 2025: Earnings Beat, $2.7 Billion Divestiture and Fresh Analyst Price Targets

Updated: December 1, 2025 Aon plc stock snapshot as of December 1, 2025 Aon plc (NYSE: AON), the global insurance and professional services broker, is trading in the middle of its 12‑month range after a busy 2025 marked by a major divestiture, solid earnings growth and continuing share buybacks. Institutional investors continue to dominate the shareholder base: recent filings show institutions holding well over 80% of the float, with one example being Ceredex Value Advisors lifting its stake to more than 136,000 shares in recent months. MarketBeat Q3 2025 earnings: A steady beat driven by risk management demand Aon’s latest
2 December 2025
Ecolab (ECL) Stock Outlook on December 1, 2025: Earnings Momentum, AI-Driven Water Tech and Wall Street Forecasts

Ecolab (ECL) Stock Outlook on December 1, 2025: Earnings Momentum, AI-Driven Water Tech and Wall Street Forecasts

On December 1, 2025, shares of Ecolab Inc. (NYSE: ECL), the global leader in water, hygiene and infection-prevention solutions, are trading near their 52‑week highs after another quarter of double‑digit earnings growth and a flurry of AI‑and‑water‑focused product launches. Ecolab sits at the intersection of three powerful themes: water scarcity, data‑center growth and corporate sustainability. That combination is increasingly shaping how Wall Street values the stock — and what investors are watching as the calendar turns to 2026. This article compiles the latest news, forecasts and analysis as of December 1, 2025, and is intended for informational purposes only, not
2 December 2025
···
U.S. Bancorp (USB) Stock on December 1, 2025: Q3 Earnings Beat, 4%+ Dividend and 2026 Forecasts

U.S. Bancorp (USB) Stock on December 1, 2025: Q3 Earnings Beat, 4%+ Dividend and 2026 Forecasts

U.S. Bancorp (NYSE: USB) heads into December 2025 as one of the more closely watched U.S. regional banks: the stock just posted record quarterly revenue, yields a dividend above 4%, and carries a “Moderate Buy” / “Buy” consensus from Wall Street — but it also faces scrutiny over insider selling, regulatory risks and the usual credit-cycle worries. U.S. Bank+2StockAnalysis+2 Below is a roundup of the latest news, forecasts and analysis as of December 1, 2025, together with what it all may mean for investors following USB. Where U.S. Bancorp Stock Stands on December 1, 2025 As of the close on
2 December 2025
···
General Dynamics Stock (GD) in December 2025: Earnings Beats, Massive Backlog and a New Legal Challenge

General Dynamics Stock (GD) in December 2025: Earnings Beats, Massive Backlog and a New Legal Challenge

Published: December 1, 2025 General Dynamics Corporation (NYSE: GD) heads into the final month of 2025 with strong earnings momentum, a record defense backlog and rising interest from Wall Street – but also a fresh legal overhang investors can’t ignore. Below is a deep dive into the latest General Dynamics stock news, 2025 results, analyst forecasts, dividend profile, and the key bull and bear arguments around GD today. Where General Dynamics Stock Stands Now As of the close on December 1, 2025, General Dynamics shares finished at $332.38, down 2.71% on the day in a broadly weak market. Even after
2 December 2025
··
Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Updated: December 1, 2025 Starbucks Corporation (NASDAQ: SBUX) closed Monday’s session at about $84.91, down roughly 2.5% on the day, leaving the coffee giant modestly positive year‑to‑date but still well below its 2021 peak.StockAnalysis+1 The pullback comes as investors digest three big storylines converging at once: Below is a detailed look at what changed today, how it fits into Starbucks’ broader turnaround plan, and how Wall Street now values SBUX heading into 2026. Starbucks stock today: price, performance and valuation As of the U.S. market close on December 1, 2025, Starbucks shares traded around: Performance snapshot: On current consensus earnings
2 December 2025
·
Southern Company (SO) Stock on December 1, 2025: Dividend Giant in a Booming Utilities Super-Cycle

Southern Company (SO) Stock on December 1, 2025: Dividend Giant in a Booming Utilities Super-Cycle

As utilities rally on AI-driven power demand and rate-cut hopes, Southern Company’s stock sits around $89 with a 3.3% dividend yield, fresh capital raises, and a wall of “Hold” ratings. Here’s what today’s news and forecasts say about SO. Southern Company stock today: price, yield and market backdrop As of the official close on December 1, 2025, shares of Southern Company (NYSE: SO) finished at $89.01, down about 2.3% on the day from a prior close of $91.12. The stock traded between $88.99 and $90.75 with volume of roughly 5.7 million shares.FinancialContent+1 That puts SO: On a total-return basis, Southern
2 December 2025
··
Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (NYSE: BMY) has suddenly become one of the most eventful big pharma names to watch as of December 1, 2025. A major lawsuit has been allowed to proceed, new cell therapy approvals are landing, hematology data at ASH 2025 is impressive, and investors are reassessing the stock’s value, dividend and medium‑term growth story. Below is a deep dive into today’s key news, current price, latest forecasts and what it all might mean for BMY stock. This article is for information only and is not investment advice. BMY Stock Snapshot on 1 December 2025 In other words: BMY is
2 December 2025
·
Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont Corporation (NYSE: NEM), the world’s largest gold miner, has turned 2025 into a breakout year. As of 1 December 2025, Newmont stock trades around $91.83, up more than 100% year-to-date after a 12% surge in November alone, closely tracking gold’s march to fresh record highs. Barron’s+1 On Monday, UBS reinforced the bullish narrative, raising its price target on NEM to $125 and reiterating a Buy rating, citing strong gold fundamentals and a streamlined asset base after a wave of divestitures. GuruFocus+1 At the same time, Newmont is churning out record free cash flow, rapidly shrinking its debt load, and
2 December 2025
·
CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

Data and news current as of December 1, 2025. This article is for informational purposes only and is not financial advice. CVS Health Stock Today: A Big 2025 Comeback, Slightly Off the Highs CVS Health Corporation (NYSE: CVS) has staged one of 2025’s quiet comeback stories. On December 1, 2025, CVS shares closed at $79.10, down about 1.6% on the day and snapping a three‑day winning streak, while the S&P 500 also slipped in a broadly weak session. The stock now sits roughly 7% below its 52‑week high of $85.15, set on October 29. MarketWatch+1 Over a longer horizon, the
2 December 2025
··
CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

Updated December 1, 2025 CME Group Inc. (NASDAQ: CME), the world’s largest derivatives exchange operator, is ending 2025 on a complicated note. On one hand, the company is posting record volumes in key asset classes, rolling out new crypto benchmarks, launching a prediction‑markets app with FanDuel and expanding in the Middle East. On the other, a rare 10‑hour data‑center failure has put its operational resilience and competitive moat under the microscope. Here’s a deep dive into what’s moving CME Group stock today, how analysts are valuing the shares, and what to watch going into 2026. CME Group Stock Today: Price,
2 December 2025
·
Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

As of the close on December 1, 2025, Parker‑Hannifin Corporation (NYSE: PH) is trading in the mid‑$850s per share, with a market capitalization of roughly $109 billion. MarketBeat+1 The stock has been one of the standout industrial names in 2025, powered by: At the same time, valuation is becoming a central question, with some models calling PH overvalued by ~30%, even as Wall Street’s fundamental analysts largely stay bullish. MarketBeat+3Simply Wall St+3Nasdaq+3 Below is a detailed, news‑driven look at Parker‑Hannifin stock, based on coverage and analysis published on and after December 1, 2025, plus the key corporate developments leading into
1 December 2025
KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

As of Monday, December 1, 2025, KKR & Co. Inc. (NYSE: KKR) is trading around $122 per share, having bounced back from its autumn lows but still sitting roughly 28% below its 52‑week high of $170.40 set in late January. Yahoo Finance+2MarketWatch+2 The alternative asset manager has just delivered a strong Q3 2025 earnings beat, is facing heightened regulatory scrutiny of private credit, and still carries bullish 12‑month price targets from Wall Street. At the same time, technical and algorithmic models are more cautious in the near term, and the stock’s valuation is rich on trailing earnings. Below is a
1 December 2025
·
HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

Date: December 1, 2025 – NYSE: HCA HCA Healthcare stock snapshot on December 1, 2025 HCA Healthcare, Inc. (NYSE: HCA), the largest for‑profit hospital operator in the United States, continues to trade near record territory as December begins. Barchart’s latest feature on the stock notes that HCA hit an all‑time high of $520 in the prior session and that shares have soared 71.5% year‑to‑date and 56.5% over the past 12 months, handily beating the Health Care Select Sector SPDR ETF (XLV). Barchart.com Technically, HCA has been trading above its 50‑day moving average since January and above its 200‑day moving average
1 December 2025
Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell International Inc. (NASDAQ: HON) ended Monday, December 1, 2025 at $190.22, down about 1.0% on the day and roughly 16% below its 52‑week high near $228.Danelfin AI+1 Despite a soft share price in 2025, the company just delivered a Q3 2025 earnings beat, raised its full‑year guidance, completed the Solstice Advanced Materials spin‑off, and is preparing a high‑profile breakup into separate Aerospace and Automation companies by 2026.Honeywell+2Fintool+2 At the same time, Honeywell faces growth concerns and mixed analyst sentiment: Bank of America recently double‑downgraded the stock to Underperform, while most Wall Street firms still rate HON a Buy/Moderate Buy
1 December 2025
··
1 … 574 575 576 577 578 … 611

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop